Picture of Neuroscientific Biopharmaceuticals logo

NSB — Neuroscientific Biopharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Neuroscientific Biopharmaceuticals Says Paul Rennie Appointed As Interim CEO

Nov 23 (Reuters) - NeuroScientific Biopharmaceuticals
Ltd  NSB.AX :
    * NON-EXECUTIVE CHAIRMAN PAUL RENNIE HAS BEEN APPOINTED AS
INTERIM
CEO
    * PAUL RENNIE WILL CONTINUE TO ACT AS CHAIRMAN, WHILST
STEPPING
INTO INTERIM CEO ROLE

Source text for Eikon:  ID:nASXbF3yFM 
Further company coverage:  NSB.AX 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Neuroscientific Biopharmaceuticals

See all news